Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic Factors |
Shim, Youngbo
(Department of Neurosurgery, Seoul National University College of Medicine)
Gwak, Ho-Shin (Department of System Cancer Science, Graduate School of Cancer Science and Policy, National Cancer Center) Kim, Sohee (Cancer Biostatistics Branch, National Cancer Center) Joo, Jungnam (Cancer Biostatistics Branch, National Cancer Center) Shin, Sang-Hoon (Neuro-Oncology Clinic, National Cancer Center) Yoo, Heon (Neuro-Oncology Clinic, National Cancer Center) |
1 | An YJ, Cho HR, Kim TM, Keam B, Kim JW, Wen H, et al. : An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients. Int J Cancer 136 : 162- 171, 2015 DOI |
2 | Balm M, Hammack J : Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 53 : 626-632, 1996 DOI |
3 | Boogerd W, Hart AA, van der Sande JJ, Engelsman E : Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 67 : 1685-1695, 1991 DOI |
4 | Bruna J, Gonzalez L, Miro J, Velasco R, Gil M, Tortosa A; Neuro-Oncology Unit of the Institute of Biomedical Investigation of Bellvitge : Leptomeningeal carcinomatosis : prognostic implications of clinical and cerebrospinal fluid features. Cancer 115 : 381-389, 2009 DOI |
5 | Chamberlain MC : Leptomeningeal metastasis. Curr Opin Oncol 22 : 627-635, 2010 DOI |
6 | Chamberlain MC : Radioisotope CSF flow studies in leptomeningeal metastases. J Neurooncol 38 : 135-140, 1998 DOI |
7 | Chamberlain MC, Kormanik PA, Glantz MJ : A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases. Neuro Oncol 3 : 42-45, 2001 DOI |
8 | Clamon G, Doebbeling B : Meningeal carcinomatosis from breast cancer : spinal cord vs. brain involvement. Breast Cancer Res Treat 9 : 213-217, 1987 DOI |
9 | Glantz MJ, Hall WA, Cole BF, Chozick BS, Shannon CM, Wahlberg L, et al. : Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer 75 : 2919-2931, 1995 DOI |
10 | Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, et al. : Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer 77 : 1315-1323, 1996 DOI |
11 | Glass JP, Melamed M, Chernik NL, Posner JB : Malignant cells in cerebrospinal fluid (CSF) : the meaning of a positive CSF cytology. Neurology 29 : 1369-1375, 1979 DOI |
12 | Grossman SA, Krabak MJ : Leptomeningeal carcinomatosis. Cancer Treat Rev 25 : 103-119, 1999 DOI |
13 | Gwak HS, Lee CH, Yang HS, Joo J, Shin SH, Yoo H, et al. : Chemoport with a non-collapsible chamber as a replacement for an Ommaya reservoir in the treatment of leptomeningeal carcinomatosis. Acta Neurochir (Wien) 153 : 1971-1978; discussion 1978, 2011 DOI |
14 | Herrlinger U, Forschler H, Kuker W, Meyermann R, Bamberg M, Dichgans J, et al. : Leptomeningeal metastasis : survival and prognostic factors in 155 patients. J Neurol Sci 223 : 167-178, 2004 DOI |
15 | Hitchins RN, Bell DR, Woods RL, Levi JA : A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5 : 1655-1662, 1987 DOI |
16 | Hladky SB, Barrand MA : Mechanisms of fluid movement into, through and out of the brain : evaluation of the evidence. Fluids Barriers CNS 11 : 26, 2014 DOI |
17 | Nakagawa H, Kubo S, Murasawa A, Nakajima S, Nakajima Y, Izumoto S, et al. : Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors. J Neurooncol 12 : 111-120, 1992 |
18 | Jayson GC, Howell A : Carcinomatous meningitis in solid tumours. Ann Oncol 7 : 773-786, 1996 DOI |
19 | Kaplan JG, DeSouza TG, Farkash A, Shafran B, Pack D, Rehman F, et al. : Leptomeningeal metastases : comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 9 : 225-229, 1990 DOI |
20 | Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, et al. : Response assessment criteria for brain metastases : proposal from the RANO group. Lancet Oncol 16 : e270-e278, 2015 DOI |
21 | Park JH, Kim YJ, Lee JO, Lee KW, Kim JH, Bang SM, et al. : Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era. Lung Cancer 76 : 387-392, 2012 DOI |
22 | Taillibert S, Laigle-Donadey F, Chodkiewicz C, Sanson M, Hoang-Xuan K, Delattre JY : Leptomeningeal metastases from solid malignancy : a review. J Neurooncol 75 : 85-99, 2005 DOI |
23 | Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky M, et al : MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol 14 : 689-700, 2012 DOI |
24 | Twijnstra A, Ongerboer de Visser BW, van Zanten AP : Diagnosis of leptomeningeal metastasis. Clin Neurol Neurosurg 89 : 79-85, 1987 DOI |
25 | Wasserstrom WR, Glass JP, Posner JB : Diagnosis and treatment of leptomeningeal metastases from solid tumors : experience with 90 patients. Cancer 49 : 759-772, 1982 DOI |
26 | Yap HY, Yap BS, Rasmussen S, Levens ME, Hortobagyi GN, Blumenschein GR : Treatment for meningeal carcinomatosis in breast cancer. Cancer 50 : 219-222, 1982 DOI |